Calidi Biotherapeutics Inc (CLDI)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Calidi Biotherapeutics Inc

Healthcare (1176)

Biotechnology (673)

(858) 794-9600

4475 Executive Drive, Suite 200, San Diego

Prossima data di guadagno

Ultimi documenti SEC

CLDI's Discussions on Twitter

Confronta CLDI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLDI Calidi Biotherapeutics Inc	1.36	25.63M	0	-23.36M	0	-0.7368
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-22	Iniziato	H.C. Wainwright	Buy
2023-10-09	Iniziato	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Confronta CLDI con altri titoli

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock - Investing.com

Calidi Biotherapeutics prices $7.5M secondary offering - MSN

Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail

Calidi Biotherapeutics (NYSE American: CLDI) Data Demonstrates Potential of Innovative Solutions to Revolutionize Cancer Care - Barchart

UMACUnusual Machines, Inc. Latest Stock News & Market Updates - StockTitan

Calidi Biotherapeutics (NYSE American: CLDI) Shares Data Supporting Proprietary Systemic Antitumor Platform - Barchart

Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN

Calidi Biotherapeutics (NYSE American: CLDI) Raises $7.5 Million Through Public Stock Offering - Barchart

If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register

Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News

Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks

Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times

Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan

Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews

SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow

Calidi prices 4.4M shares at $1.69 in public offering - TipRanks

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times

Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan

Calidi announces common stock offering, no amount given - TipRanks

Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch

Calidi Biotherapeutics plans stock offering - Investing.com India

Calidi Biotherapeutics plans stock offering By Investing.com - Investing.com Canada

Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times

Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan

Calidi Biotherapeutics Advances with FDA Clearance and Funding - TipRanks

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times

Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Calidi to present data supporting RTNova at upcoming conferences - TipRanks

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times

Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance

Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN

CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa

CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com

Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga

Calidi Biotherapeutics secures $2 million in equity financing - Investing.com

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times

Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - ForexTV.com

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CLDI